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This project focused on formulation and investigation of interplay effects of 
ethosomes, ethanol and microwave for enhanced skin drug retention with 
minimal systemic absorption. The microwave was used to modify the skin 
barrier properties to enhance ethosomes and/or drug penetration/and drug 
retention which is detrimental to treat local malignant melanoma and to 
enhance patient compliance. Ethosomes are known to fuse with skin to enable 
local drug retention. Pre-treatment of skin with microwave and applying 
liquified medicine is deemed to “cement” the skin thereby raising skin drug 
deposition. 5-fluorouracil loaded ethosomes were prepared and subjected 
physicochemical characterization. The molecular characteristics of untreated, 
microwave and/or ethosomes and/or ethanol-treated skins were examined by 
ATR-FTIR and raman spectroscopy, DSC and SEM techniques. The skin drug
retention was promoted using larger ethosomes with negative zeta potentials 
that repelled anionic lipids of skin and hindered vesicle and/or anionic drug 
penetration into deep layers. Due to low ethanol, they were less able to fluidize 
the lipid and defluidize the protein domains at epidermis to enlarge aqueous 
pores for drug permeation. Pre-treatment of skin by 2450 MHz microwave 
for 2.5 min further increased skin drug penetration and retention of E5 
ethosomes and provided lower drug permeation than cases treated for 1.15 min 
and 5 min. Pre-treating skin with microwave fluidized lipid and defluidized 
protein domains of skin that promoted transdermal drug penetration. A 2.5 
min treatment however might be accompanied by specific dermal protein 
fluidization via C=O moiety which translated to macromolecular swelling, 
The study investigated the aerosolization and inhalation profiles of 
rifampicin-oleic acid first generation liquid and solid nanoemulsions and 
their respective chitosan- and chitosan-folate conjugate-decorated second 
and third generation nanoemulsions. The liquid nanoemulsions were prepared 
by spontaneous emulsification method and had their size, zeta potential, 
polydispersity index, morphology, pH, viscosity, surface tension, density, 
refractive index, drug content, drug release, aerosolization and inhalation 
profiles characterized. The first, second and third generation nanoemulsions 
had average droplet sizes of 43.89 ± 0.36 nm, 52.12 ± 0.36 nm and 59.69 ± 0.26 
nm, with narrow polydispersity indices at 0.16 ± 0.03, 0.25 ± 0.03 and 0.23 
± 0.01 respectively. They exhibited desirable pH, surface tension, viscosity, 
refractive index, density, and viscosity attributes for pulmonary rifampicin 
administration. The second generation nanoemulsion was characterized by 
relatively low levels of burst drug release due to intimate chitosan packing 
at the oil globules’ surfaces and viscosifying effect on continuous phase, 
which was unattainable by the branched folate conjugate of chitosan. All 
nanoemulsions demonstrated more than 95 % aerosol output and inhalation 
efficiency greater than 75 % when delivered by nebulization. The aerosol 
output, aerosolized and inhaled fine particle fractions were primarily 
governed by the size and surface tension of nanoemulsions in an inverse 
relationship. The first, second and third generation nanoemulsions were 
converted to their corresponding solid counterparts by spray drying method. 
The spray-dried solid first, second and third generation nanoemulsions 
achieved particle sizes of 7.05 ± 0.38 μm, 7.96 ± 0.33 and 5.45 ± 0.38 μm 
narrowing of intercellular spaces at lower skin layers, increased drug retention 
and reduced drug permeation. Ethosomes in combination with microwave at 
2450 MHz for 2.5 min promoted significant drug deposition in skin from 
ethosomes in vivo with reduced systemic absorption. Pre-treatment of human
melanoma cells with microwave exerted cytotoxic effect and also 
facilitated the intracellular ethosomes accumulation by fluidizing the cell 
membrane phospholipids reflected by a significant increase in wavenumber 
corresponding to symmetric phosphate moiety. The endocytosis was 
primarily promoted by lipid rafts pathway where a significant reduction 
in fluorescence intensity was observed when melanoma cells were pre-
incubated with nystatin. Combined microwave and ethanol pretreatment 
of skin increased skin drug retention and decreased permeation of aqueous 
5-fluorouracil solution. The combination fluidized the skin lipidic domains, 
defluidized the hydrophilic regimens causing an increase in aqueous pores 
population and their sizes. The summative effect translated into an increased 
drug penetration, permeation and retention of drug solution in the skin. When 
microwave pre-treatment was combined with 100 μl ethanol, rapid movement 
of ethanol from epidermis to dermis under the gravity bringing extracted 
epidermal lipids downwards and accumulating them in dermis in addition 
to fluidization of the extracellular proteins at C-N moieties. The expanded 
proteins structure and epidermal lipids accumulation in dermis promoted skin 
drug retention by narrowing the permeation pathways and formation of an 
additional lipid barrier consisting of ceramide and palmitic acid in dermis.
respectively, with sustained drug release behavior as compared to their 
associated nanoemulsions due to their large particle sizes and solid nature. 
The powder exhibited an aerosol output of > 65 % when delivered using 
Handihaler. The mass median aerodynamic diameters of < 5 μm was 
achieved for all spray-dried solid nanoemulsions, due to their lower tapped 
densities resulting in inhaled fraction of > 30 %. Among physicochemical 
properties of spray-dried nanoemulsions, increased circularity and lower 
tapped density have been found to improve aerosolization of powder from 
dry powder inhaler, while higher span value tends to improve the FPF. Due 
to significantly higher aerosolization potential and inhalation efficiency of 
liquid nanoemulsions, they were evaluated for their cellular internalization, 
safety and pharmacokinetics behaviors in cell culture and animal models. 
A significantly higher level of cellular internalization was observed with 
third generation nanoemulsion when compared to second generation liquid 
nanoemulsion due to double receptors targeting in the former via folate 
and acetylglucosamine moiety of chitosan. The liquid nanoemulsions 
were regarded as safe and biocompatible with reference to rifampicin in 
therapeutic doses, because macrophages remain viable (> 80 %) following 
their incubation with nanoemulsions. The pharmacokinetics analysis 
revealed that nanoemulsion succeed in maintaining therapeutic level of 
drug in the plasma for 16 h after intratracheal drug administration, with 
higher lung drug concentration in case of third generation nanoemulsion. 
Thus, both liquid and solid nanoemulsions are suitable for use as rifampicin 
carrier in the treatment of tuberculosis.
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